Phase 2 trial finds mezagitamab increases platelet counts in adults with persistent or chronic ITP
Mezagitamab increased platelet counts in adults with chronic or persistent immune thrombocytopenia in this early trial.
A multicenter, double-blind, randomized, placebo-controlled Phase 2 trial in 41 adults with persistent or chronic ITP found 91% of participa…
Mezagitamab helped 91% of adults with chronic low platelet counts reach target levels, while only 23% on placebo did so in this early trial.
Huaiqihuang Granule Improves Bleeding in Childhood CITP: 71.74% Effectiveness vs 45.65% Placebo
Could a Traditional Chinese Medicine Help Children with Immune Thrombocytopenia?
In a 216-child RCT, Huaiqihuang Granule (HQH) showed superior efficacy over placebo in reducing bleeding severity and achieving platelet res…
A traditional Chinese medicine helped 72% of children with chronic immune thrombocytopenia reduce bleeding and boost platelet counts compare…